US Bancorp’s GeneDx Holdings WGS Stock Holding History

US Bancorp’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$43.6K	Sell	635 -798	-56%	-$45.4K	﹤0.01%	2862
2026 Q1	$92K	Buy	1,433 +828	+137%	+$75.5K	﹤0.01%	2431
2025 Q4	$78.7K	Sell	605 -555	-48%	-$76.2K	﹤0.01%	2490
2025 Q3	$125K	Sell	1,160 -406	-26%	-$44.2K	﹤0.01%	2241
2025 Q2	$145K	Buy	1,566 +1,001	+177%	+$78.6K	﹤0.01%	2226
2025 Q1	$50K	Buy	565 +548	+3,224%	+$47.5K	﹤0.01%	2748
2024 Q4	$1.31K	Buy	+17	New	+$1.19K	﹤0.01%	3927
2021 Q4	–	Sell	-16	Closed	-$4K	–	4239
2021 Q3	$4K	Buy	16 +1	+7%	+$343	﹤0.01%	3736
2021 Q2	$7K	Buy	15 +14	+1,400%	+$6.01K	﹤0.01%	3536
2021 Q1	$0	Buy	+1	New	+$520	﹤0.01%	3973

Other funds holding WGS

Corvex Management New York $3.27B AUM 38.53% 1-Year Est. Return

Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

US Bancorp's WGS Position: Q2 2026 in Review

US Bancorp reduced its GeneDx Holdings (WGS) stake by 56% in Q2 2026, selling an estimated $45.4K and leaving 635 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

US Bancorp first reported a position in WGS in Q1 2021 and has held it in 10 quarters since. The position peaked at $145K in Q2 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

US Bancorp held 635 shares of GeneDx Holdings worth $43.6K as of Q2 2026.
US Bancorp sold 798 GeneDx Holdings shares in Q2 2026, an estimated $45.4K.
GeneDx Holdings made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2862 holding.
US Bancorp first reported a position in GeneDx Holdings in Q1 2021 and has held it in 10 quarters since.
US Bancorp's GeneDx Holdings position peaked at $145K in Q2 2025.
223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.